Characterization and Validation of Somatic Mutation Spectrum to Reveal Heterogeneity in Gastric Cancer by Single Cell Sequencing

Lihua Peng,Rui Xing,Dongbing Liu,Li Bao,Wenxiang Cheng,Hongyi Wang,Yuan Yu,Xiaofeng Liu,Lu Jiang,Yan Wu,Zhongxue An,Qiaoyi Liang,Ryong Nam Kim,Young Kee Shin,Huanming Yang,Jian Wang,Jun Yu,Xiuqing Zhang,Xun Xu,Jiaan Yang,Kui Wu,Shida Zhu,Youyong Lu

DOI: https://doi.org/10.1016/j.scib.2018.12.014

IF: 18.9

2019-01-01

Science Bulletin

Abstract:Gastric cancer (GC) is a highly heterogeneous disease with multiple cellular types and poor prognosis. However, the cellular evolution and molecular basis of GC at the individual intra-tumor level has not been well demonstrated. We performed single-cell whole exome sequencing to detect somatic single-nucleotide variants (SNVs) and significantly mutated genes (SMGs) among 34 tumor cells and 9 normal cells from a patient with GC. The Complete Prediction for Protein Conformation (CPPC) approach directly predicting the folding conformation of the protein 3D structure with Protein Folding Shape Code, combined with functional experiments were used to confirm the characterization of mutated SMGs in GC cells. We identified 201 somatic SNVs, including 117 non-synonymous mutations in GC cells. Further analysis identified 24 significant mutated genes (SMGs) in single cells, for which a single amino acid change might affect protein conformation. Among them, two genes (CDC27 and FLG) that were mutated only in single cells but not in the corresponding tumor tissue, were recurrently present in another GC tissue cohort, and may play a potential role to promote carcinogenesis, as confirmed by functional characterization. Our findings showed a mutational landscape of GC at intra-tumor level for the first time and provided opportunities for understanding the heterogeneity and individualized target therapy for this disease.